Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 153741, 13 pages
http://dx.doi.org/10.1155/2014/153741
Review Article

Bimodal Imaging Probes for Combined PET and OI: Recent Developments and Future Directions for Hybrid Agent Development

1Biomedical Chemistry, Department of Clinical Radiology and Nuclear Medicine, Medical Faculty Mannheim of Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany
2Molecular Imaging and Radiochemistry, Department of Clinical Radiology and Nuclear Medicine, Medical Faculty Mannheim of Heidelberg University, 68167 Mannheim, Germany
3McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, QC, Canada H3A 2B4

Received 11 February 2014; Accepted 18 March 2014; Published 16 April 2014

Academic Editor: Patrick Riss

Copyright © 2014 Uwe Seibold et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. R. Cherry, “Multimodality in vivo imaging systems: twice the power or double the trouble?” Annual Review of Biomedical Engineering, vol. 8, pp. 35–62, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. S. R. Cherry, “Multimodality imaging: beyond PET/CT and SPECT/CT,” Seminars in Nuclear Medicine, vol. 39, no. 5, pp. 348–353, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Cheon and J. H. Lee, “Synergistically integrated nanoparticles as multimodal probes for nanobiotechnology,” Accounts of Chemical Research, vol. 41, no. 12, pp. 1630–1640, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. T. Buckle, P. T. K. Chin, and F. W. B. van Leeuwen, “(Non-targeted) radioactive/fluorescent nanoparticles and their potential in combined pre-and intraoperative imaging during sentinel lymph node resection,” Nanotechnology, vol. 21, no. 48, pp. 482001–482010, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Nahrendorf, E. Keliher, B. Marinelli et al., “Hybrid PET-optical imaging using targeted probes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 17, pp. 7910–7915, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. G. M. van Dam, G. Themelis, L. M. A. Crane et al., “Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results,” Nature Medicine, vol. 17, no. 10, pp. 1315–1319, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. P. T. Chin, C. A. Beekman, T. Buckle, L. Josephson, and F. W. van Leeuwen, “Multispectral visualization of surgical safety-margins using fluorescent marker seeds,” The American Journal of Nuclear Medicine and Molecular Imaging, vol. 2, pp. 151–162, 2012. View at Google Scholar
  8. M. S. Bradbury, E. Phillips, P. H. Montero et al., “Clinically-translated silica nanoparticles as dual-modality cancer-targeted probes for image-guided surgery and interventions,” Integrative Biology, vol. 5, pp. 74–86, 2013. View at Google Scholar
  9. E. J. T. Rutgers, “Sentinel node biopsy: interpretation and management of patients with immunohistochemistry-positive sentinel nodes and those with micrometastases,” Journal of Clinical Oncology, vol. 26, no. 5, pp. 698–702, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. C. M. Balch, S.-J. Soong, J. E. Gershenwald et al., “Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system,” Journal of Clinical Oncology, vol. 19, no. 16, pp. 3622–3634, 2001. View at Google Scholar · View at Scopus
  11. L. Vermeeren, R. A. Valdés Olmos, W. Meinhardt et al., “Value of SPECT/CT for detection and anatomic localization of sentinel lymph nodes before laparoscopic sentinel node lymphadenectomy in prostate carcinoma,” Journal of Nuclear Medicine, vol. 50, no. 6, pp. 865–870, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Kuil, T. Buckle, and F. W. van Leeuwen, “Imaging agents for the chemokine receptor 4 (CXCR4),” Chemical Society Reviews, vol. 41, pp. 5239–5261, 2012. View at Google Scholar
  13. J. C. Knight and F. R. Wuest, “Nuclear (PET/SPECT) and optical imaging probes targeting the CXCR4 chemokine receptor,” Medicinal Chemistry Communications, vol. 3, pp. 1039–1053, 2012. View at Google Scholar
  14. K. Yan, P. Li, H. Zhu et al., “Recent advances in multifunctional magnetic nanoparticles and applications to biomedical diagnosis and treatment,” RSC Advances, vol. 3, pp. 10598–10618, 2013. View at Google Scholar
  15. A. Louie, “Multimodality imaging probes: design and challenges,” Chemical Reviews, vol. 110, no. 5, pp. 3146–3195, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Liu, D. Li, C. W. Huang et al., “Efficient construction of PET/fluorescence probe based on sarcophagine cage: an opportunity to integrate diagnosis with treatment,” Molecular Imaging and Biology, vol. 14, pp. 718–724, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. R. H. Kimura, Z. Miao, Z. Cheng, S. S. Gambhir, and J. R. Cochran, “A dual-labeled knottin peptide for PET and near-infrared fluorescence imaging of integrin expression in living subjects,” Bioconjugate Chemistry, vol. 21, no. 3, pp. 436–444, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. P. Paudyal, B. Paudyal, Y. Iida et al., “Dual functional molecular imaging probe targeting CD20 with PET and optical imaging,” Oncology Reports, vol. 22, no. 1, pp. 115–119, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Weissleder and U. Mahmood, “Molecular imaging,” Radiology, vol. 219, no. 2, pp. 316–333, 2001. View at Google Scholar · View at Scopus
  20. K. Shah and R. Weissleder, “Molecular optical imaging: applications leading to the development of present day therapeutics,” NeuroRx, vol. 2, no. 2, pp. 215–225, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. J. V. Frangioni, “In vivo near-infrared fluorescence imaging,” Current Opinion in Chemical Biology, vol. 7, no. 5, pp. 626–634, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. J. M. Park and S. S. Gambhir, “Multimodality radionuclide, fluorescence, and bioluminescence small-animal imaging,” Proceedings of the IEEE, vol. 93, no. 4, pp. 771–782, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. J. P. Holland, G. Normand, A. Ruggiero, J. S. Lewis, and J. Grimm, “Intraoperative imaging of positron emission tomographic radiotracers using cerenkov luminescence emissions,” Molecular Imaging, vol. 10, no. 3, pp. 177–186, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. J. C. Park, M. K. Yu, G. I. An et al., “Facile preparation of a hybrid nanoprobe for triple-modality optical/PET/MR imaging,” Small, vol. 6, no. 24, pp. 2863–2868, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Azhdarinia, N. Wilganowski, H. Robinson et al., “Characterization of chemical, radiochemical and optical properties of a dual-labeled MMP-9 targeting peptide,” Bioorganic & Medicinal Chemistry, vol. 19, no. 12, pp. 3769–3776, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. W. B. Edwards, B. Xu, W. Akers et al., “Agonist—antagonist dilemma in molecular imaging: evaluation of a monomolecular multimodal imaging agent for the somatostatin receptor,” Bioconjugate Chemistry, vol. 19, no. 1, pp. 192–200, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. J. S. Kim, Y.-H. Kim, J. H. Kim et al., “Development and in vivo imaging of a PET/MRI nanoprobe with enhanced NIR fluorescence by dye encapsulation,” Nanomedicine, vol. 7, no. 2, pp. 219–229, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. L. Sampath, S. Kwon, S. Ke et al., “Dual-labeled trastuzumab-based imaging agent for the detection of human epidermal growth factor receptor 2 overexpression in breast cancer,” Journal of Nuclear Medicine, vol. 48, no. 9, pp. 1501–1510, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. L. Sampath, W. Wang, and E. M. Sevick-Muraca, “Near infrared fluorescent optical imaging for nodal staging,” Journal of Biomedical Optics, vol. 13, no. 4, Article ID 041312, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Kuil, T. Buckle, J. Oldenburg et al., “Hybrid peptide dendrimers for imaging of chemokine receptor 4 (CXCR4) expression,” Molecular Pharmaceutics, vol. 8, no. 6, pp. 2444–2453, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Kuil, T. Buckle, H. Yuan et al., “Synthesis and evaluation of a bimodal CXCR4 antagonistic peptide,” Bioconjugate Chemistry, vol. 22, no. 5, pp. 859–864, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. W. Wang, S. Ke, S. Kwon et al., “A new optical and nuclear dual-labeled imaging agent targeting interleukin 11 receptor alpha-chain,” Bioconjugate Chemistry, vol. 18, no. 2, pp. 397–402, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. J. P. Houston, S. Ke, W. Wang, C. Li, and E. M. Sevick-Muraca, “Quality analysis of in vivo near-infrared fluorescence and conventional gamma images acquired using a dual-labeled tumor-targeting probe,” Journal of Biomedical Optics, vol. 10, no. 5, Article ID 054010, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. W. B. Edwards, W. J. Akers, Y. Ye et al., “Multimodal imaging of integrin receptor-positive tumors by bioluminescence, fluorescence, gamma scintigraphy, and single-photon emission computed tomography using a cyclic RGD peptide labeled with a near-infrared fluorescent dye and a radionuclide,” Molecular Imaging, vol. 8, no. 2, pp. 101–110, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. C. Li, W. Wang, Q. Wu et al., “Dual optical and nuclear imaging in human melanoma xenografts using a single targeted imaging probe,” Nuclear Medicine and Biology, vol. 33, no. 3, pp. 349–358, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. Z. Zhang, K. Liang, S. Bloch, M. Berezin, and S. Achilefu, “Monomolecular multimodal fluorescence-radioisotope imaging agents,” Bioconjugate Chemistry, vol. 16, no. 5, pp. 1232–1239, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. C. A. Boswell, P. K. Eck, C. A. S. Regino et al., “Synthesis, characterization, and biological evaluation of integrin αvβ3-targeted PAMAM dendrimers,” Molecular Pharmaceutics, vol. 5, no. 4, pp. 527–539, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. D. R. Vera, D. J. Hall, C. K. Hoh, P. Gallant, L. M. McIntosh, and R. F. Mattrey, “Cy5.5-DTPA-galactosyl-dextran: a fluorescent probe for in vivo measurement of receptor biochemistry,” Nuclear Medicine and Biology, vol. 32, no. 7, pp. 687–693, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. N. Mitchell, T. L. Kalber, M. S. Cooper et al., “Incorporation of paramagnetic, fluorescent and PET/SPECT contrast agents into liposomes for multimodal imaging,” Biomaterials, vol. 34, pp. 1179–1192, 2013. View at Google Scholar
  40. Z. Yang, S. Zheng, W. J. Harrison et al., “Long-circulating near-infrared fluorescence core-cross-linked polymeric micelles: synthesis, characterization, and dual nuclear/optical imaging,” Biomacromolecules, vol. 8, no. 11, pp. 3422–3428, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. S. K. Pandey, A. L. Gryshuk, M. Sajjad et al., “Multimodality agents for tumor imaging (PET, fluorescence) and photodynamic therapy. A possible “see and treat” approach,” Journal of Medicinal Chemistry, vol. 48, no. 20, pp. 6286–6295, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. E. R. Ranyuk, N. Cauchon, H. Ali, R. Lecomte, B. Guérin, and J. E. Van Lier, “PET imaging using64Cu-labeled sulfophthalocyanines: synthesis and biodistribution,” Bioorganic & Medicinal Chemistry Letters, vol. 21, no. 24, pp. 7470–7473, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. R. Lebel, N. Zarifyussefian, M. Letendre-Jauniaux et al., “Ultra-high sensitivity detection of bimodal probes at ultra-low noise for combined fluorescence and positron emission tomography imaging,” vol. 8574 of Proceedings of SPIE, pp. 8574–8580, 2013.
  44. E. Ranyuk, R. Lebel, Y. Berube-Lauziere et al., “(68)Ga/DOTA- and (64)Cu/NOTA-phthalocyanine conjugates as fluorescent/PET bimodal imaging probes,” Bioconjugate Chemistry, vol. 24, pp. 1624–1633, 2013. View at Google Scholar
  45. T. Priem, C. Bouteiller, D. Camporese et al., “A novel sulfonated prosthetic group for [F-18]-radiolabelling and imparting water solubility of biomolecules and cyanine fluorophores,” Organic & Biomolecular Chemistry, vol. 11, pp. 469–479, 2013. View at Google Scholar
  46. J. A. Hendricks, E. J. Keliher, D. P. Wan, S. A. Hilderbrand, R. Weissleder, and R. Mazitschek, “Synthesis of [F-18]BODIPY: bifunctional reporter for hybrid optical/positron emission tomography imaging,” Angewandte Chemie International Edition, vol. 51, pp. 4603–4606, 2012. View at Google Scholar
  47. H. Xu, K. Baidoo, A. J. Gunn et al., “Design, synthesis, and characterization of a dual modality positron emission tomography and fluorescence imaging agent for monoclonal antibody tumor-targeted imaging,” Journal of Medicinal Chemistry, vol. 50, no. 19, pp. 4759–4765, 2007. View at Publisher · View at Google Scholar · View at Scopus
  48. C. Bernhard, M. Moreau, D. Lhenry et al., “DOTAGA-anhydride: a valuable building block for the preparation of DOTA-like chelating agents,” Chemistry—A European Journal, vol. 18, pp. 7834–7841, 2012. View at Google Scholar
  49. S. C. Ghosh, P. Ghosh, N. Wilganowski et al., “Multimodal chelation platform for near-infrared fluorescence/nuclear imaging,” Journal of Medicinal Chemistry, vol. 56, pp. 406–416, 2013. View at Google Scholar
  50. B. Wängler, R. Schirrmacher, P. Bartenstein, and C. Wängler, “Chelating agents and their use in radiopharmaceutical sciences,” Mini Reviews in Medicinal Chemistry, vol. 11, pp. 968–983, 2011. View at Google Scholar
  51. T. W. Liu, J. M. Stewart, T. D. MacDonald et al., “Biologically-targeted detection of primary and micro-metastatic ovarian cancer,” Theranostics, vol. 3, pp. 420–427, 2013. View at Google Scholar
  52. G. Ren, G. Blum, M. Verdoes et al., “Non-invasive imaging of cysteine cathepsin activity in solid tumors using a64Cu-labeled activity-based probe,” PLoS ONE, vol. 6, no. 11, Article ID e28029, 2011. View at Publisher · View at Google Scholar · View at Scopus
  53. B. Behnam Azad, C.-F. Cho, J. D. Lewis, and L. G. Luyt, “Synthesis, radiometal labeling and in vitro evaluation of a targeted PPIX derivative,” Applied Radiation and Isotopes, vol. 70, no. 3, pp. 505–511, 2012. View at Publisher · View at Google Scholar · View at Scopus
  54. Y. Zhang, H. Hong, G. W. Severin et al., “ImmunoPET and near-infrared fluorescence imaging of CD105 expression using a monoclonal antibody dual-labeled with 89Zr and IRDye 800CW,” The American Journal of Translational Research, vol. 4, pp. 333–346, 2012. View at Google Scholar
  55. R. Cohen, M. A. Stammes, I. H. de Roos, M. Stigter-van Walsum, G. W. Visser, and G. A. van Dongen, “Inert coupling of IRDye800CW to monoclonal antibodies for clinical optical imaging of tumor targets,” European Journal of Nuclear Medicine and Molecular Imaging Research, vol. 1, no. 31, 2011. View at Google Scholar
  56. H. Hong, Y. Zhang, G. W. Severin et al., “Multimodality imaging of breast cancer experimental lung metastasis with bioluminescence and a monoclonal antibody dual-labeled with Zr-89 and IRDye 800CW,” Molecular Pharmacology, vol. 9, pp. 2339–2349, 2012. View at Google Scholar
  57. Y. Zhang, H. Hong, J. W. Engle et al., “Positron emission tomography and optical imaging of tumor CD105 expression with a dual-labeled monoclonal antibody,” Molecular Pharmaceutics, vol. 9, no. 3, pp. 645–653, 2012. View at Publisher · View at Google Scholar · View at Scopus
  58. L. Sampath, S. Kwon, M. A. Hall, R. E. Price, and E. M. Sevick-Muraca, “Detection of cancer metastases with a dual-labeled near- infrared/positron emission tomography imaging agent,” Translational Oncology, vol. 3, no. 5, pp. 307–318, 2010. View at Publisher · View at Google Scholar · View at Scopus
  59. M. A. Hall, M. B. Aldrich, A. Azhdarinia et al., “Quantifying multimodal contrast agent biological activity using near-infrared flow cytometry,” Contrast Media & Molecular Imaging, vol. 7, no. 3, pp. 338–345, 2012. View at Publisher · View at Google Scholar · View at Scopus
  60. R. Ting, T. A. Aguilera, J. L. Crisp et al., “Fast18F labeling of a near-infrared fluorophore enables positron emission tomography and optical imaging of sentinel lymph nodes,” Bioconjugate Chemistry, vol. 21, no. 10, pp. 1811–1819, 2010. View at Publisher · View at Google Scholar · View at Scopus
  61. X. Lin, J. Xie, G. Niu et al., “Chimeric ferritin nanocages for multiple function loading and multimodal imaging,” Nano Letters, vol. 11, no. 2, pp. 814–819, 2011. View at Publisher · View at Google Scholar · View at Scopus
  62. S. H. Li, B. Goins, L. J. Zhang, and A. D. Bao, “Novel multifunctional theranostic liposome drug delivery system: construction, characterization, and multimodality MR, near-infrared fluorescent, and nuclear imaging,” Bioconjugate Chemistry, vol. 23, pp. 1322–1332, 2012. View at Google Scholar
  63. A. Ruggiero, C. H. Villa, E. Bander et al., “Paradoxical glomerular filtration of carbon nanotubes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 27, pp. 12369–12374, 2010. View at Publisher · View at Google Scholar · View at Scopus
  64. L. Stelter, J. G. Pinkernelle, R. Michel et al., “Modification of aminosilanized superparamagnetic nanoparticles: feasibility of multimodal detection using 3T MRI, small animal PET, and fluorescence imaging,” Molecular Imaging and Biology, vol. 12, no. 1, pp. 25–34, 2010. View at Publisher · View at Google Scholar · View at Scopus
  65. M. Nahrendorf, H. Zhang, S. Hembrador et al., “Nanoparticle PET-CT imaging of macrophages in inflammatory atherosclerosis,” Circulation, vol. 117, no. 3, pp. 379–387, 2008. View at Publisher · View at Google Scholar · View at Scopus
  66. D. W. Hwang, H. Y. Ko, S.-K. Kim, D. Kim, D. S. Lee, and S. Kim, “Development of a quadruple imaging modality by using nanoparticles,” Chemistry—A European Journal, vol. 15, no. 37, pp. 9387–9393, 2009. View at Publisher · View at Google Scholar · View at Scopus
  67. J. Xie, K. Chen, J. Huang et al., “PET/NIRF/MRI triple functional iron oxide nanoparticles,” Biomaterials, vol. 31, no. 11, pp. 3016–3022, 2010. View at Publisher · View at Google Scholar · View at Scopus
  68. Q. Liu, M. Chen, Y. Sun et al., “Multifunctional rare-earth self-assembled nanosystem for tri-modal upconversion luminescence /fluorescence /positron emission tomography imaging,” Biomaterials, vol. 32, pp. 8243–8253, 2011. View at Publisher · View at Google Scholar · View at Scopus
  69. J. Zhou, M. Yu, Y. Sun et al., “Fluorine-18-labeled Gd3+/Yb3+/Er3+ co-doped NaYF4 nanophosphors for multimodality PET/MR/UCL imaging,” Biomaterials, vol. 32, no. 4, pp. 1148–1156, 2011. View at Publisher · View at Google Scholar · View at Scopus
  70. K. Chen, Z.-B. Li, H. Wang, W. Cai, and X. Chen, “Dual-modality optical and positron emission tomography imaging of vascular endothelial growth factor receptor on tumor vasculature using quantum dots,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 35, no. 12, pp. 2235–2244, 2008. View at Publisher · View at Google Scholar · View at Scopus
  71. W. Cai, K. Chen, Z.-B. Li, S. S. Gambhir, and X. Chen, “Dual-function probe for PET and near-infrared fluorescence imaging of tumor vasculature,” Journal of Nuclear Medicine, vol. 48, no. 11, pp. 1862–1870, 2007. View at Publisher · View at Google Scholar · View at Scopus
  72. F. Ducongé, T. Pons, C. Pestourie et al., “Fluorine-18-labeled phospholipid quantum dot micelles for in vivo multimodal imaging from whole body to cellular scales,” Bioconjugate Chemistry, vol. 19, no. 9, pp. 1921–1926, 2008. View at Publisher · View at Google Scholar · View at Scopus
  73. M. L. Schipper, Z. Cheng, S.-W. Lee et al., “MicroPET-based biodistribution of quantum dots in living mice,” Journal of Nuclear Medicine, vol. 48, no. 9, pp. 1511–1518, 2007. View at Publisher · View at Google Scholar · View at Scopus
  74. X. Michalet, F. F. Pinaud, L. A. Bentolila et al., “Quantum dots for live cells, in vivo imaging, and diagnostics,” Science, vol. 307, no. 5709, pp. 538–544, 2005. View at Publisher · View at Google Scholar · View at Scopus